Propofol Versus the Use of Dexmedetomidine as a Sedative Agent for Colonosopy

Tanta University100 enrolled

Overview

Dexmedetomidine as a Sedative Agent for Patients Presented for Lower Gastrointestinal Endoscopy

Propofol Versus the Use of Dexmedetomidine as a Sedative Agent for Patients Presented for Lower Gastrointestinal Endoscopy

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

100

Conditions

Colonic Diseases

Interventions

PropofolDRUG

propofol 1.5 mg/kg slow intravenously, followed by maintenance dose of 0.5 mg/kg/h throughout the procedure.

DexmedetomidineDRUG

dexmedetomidine 1 ug/kg over 10 minutes as a bolus dose followed by continuous infusion at a dose of 0.5 ug/kg/h as maintenance dose throughout the procedure

Eligibility

Sex: ALLMin age: 25 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * aged 25-45 years, * ASA class I or II, * who are scheduled for elective outpatient colonoscopy Exclusion Criteria: * refused to give informed consent * if they had known hypersensitivity to the used drugs * patients with morbidly obese patients * patients with increased risk for airway obstruction as obstructive sleep apnea, * Liver diseases

Locations (1)

Sameh Abdelkhalek Ahmed

Zagazig, Egypt

RECRUITING

Outcomes

Primary Outcomes

Number of patients with adequate sedation

the number of patients adequately sedated

Time frame: 6 months

Central Contacts

Sherief Abd-Elsalam, MD

CONTACT

00201095159522 sheriefabdelsalam@yahoo.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.